Home About Indications Product News Resources LambdaVision, Inc. is commercializing a retinal implant to restore vision for the millions of patients suffering from retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Both RP and AMD lead to the loss of photoreceptor cells, and the retinal implant developed by LambdaVision is inserted behind the retina to replace the function of these damaged cells. News LambdaVision Selected for the Global 1000 Showcase and Conference March 17, 2014 LambdaVision is one of eight companies selected to be featured at Global 1000's Startups/High-Growth Company Showcases. Gloria Kolb will be presenting at the conference held in Washington, DC on March 19-20, 2014 and will discuss LambdaVision's recent successes and future directions. Click here for further information about the event. LambdaVision CEO to Present at the 23rd Annual CMOC Symposium March 14, 2014 LambdaVision CEO, Dr. Nicole Wagner, will present recent advances in the development of protein-based retinal implants at the 23rd Annual Connecticut Microelectronics and Optoelectronics Consortium (CMOC) Symposium on April 9th, 2014 in Storrs, CT. Hartford Business Journal Highlights CCAT Grant Award February 19, 2014 Hartford Business Journal highlights a recent grant awarded to LambdaVision by the Connecticut Center for Advanced Technology (CCAT). The article can be found here. Home | About | Indications | Product | News | Resources © 2009 LambdaVision, Inc. All Rights Reserved. Website by J. A. Greco.